Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Meta-Analyses of Randomized Controlled Trials

    Brian A. Swiglo, Mihaela Cosma, David N. Flynn, David M. Kurtz, Matthew L. LaBella, Rebecca J. Mullan, Patricia J. Erwin, Víctor M. Montori
    From the encyclopedia
    Spironolactone →

    powerful topical and oral anti-androgen used mostly by women

    Metformin →

    diabetes drug with anti-inflammatory, immunomodulatory, and insulin-sensitizing properties

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Image
    Studysummary This study suggests that antiandrogens may slightly reduce hirsutism severity compared to placebo, but evidence is weak and their relative efficacy remains uncertain.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    In a systematic review and meta-analysis of 12 randomized controlled trials (RCTs) with low methodological quality, antiandrogens were found to be mildly effective in treating hirsutism. The review, which included 18 comparisons and used studies up to May 2006, showed that antiandrogens reduced Ferriman-Gallwey scores by 3.9 compared to placebo, with no inconsistency in results (I(2) = 0%). Spironolactone and flutamide were more effective than metformin, reducing hirsutism scores by 1.3 and 5.0, respectively. Combination therapies, such as spironolactone or finasteride with contraceptives, and flutamide with metformin, were superior to monotherapy with contraceptives and metformin. The number needed to treat (NNT) ranged from two to five women for one to notice improvement. However, only three RCTs included patient self-assessments, indicating a need for more patient-centered research.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results